38
Participants
Start Date
November 19, 2021
Primary Completion Date
October 26, 2023
Study Completion Date
May 8, 2024
Ravulizumab
Intravenous dosing will consist of a loading dose followed by maintenance doses administered every 8 weeks (q8w). The maintenance dosing will be initiated 2 weeks after the loading dose is administered.
Placebo
Intravenous dosing will consist of a loading dose followed by maintenance doses administered q8w. The maintenance dosing will be initiated 2 weeks after the loading dose is administered.
Research Site, Camperdown
Research Site, Seoul
Research Site, New York
Research Site, Torino
Research Site, Manhasset
Research Site, Campinas
Research Site, A Coruña
Research Site, Pittsburgh
Research Site, Washington D.C.
Research Site, Rozzano
Research Site, Milan
Research Site, Baltimore
Research Site, Junggu
Research Site, Brescia
Research Site, Pavia
Research Site, Chapel Hill
Research Site, Durham
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Charleston
Research Site, Atlanta
Research Site, Toulouse
Research Site, Oviedo
Research Site, Udine
Research Site, Taoyuan
Research Site, Tampa
Research Site, Istanbul
Research Site, Daejeon
Research Site, Las Palmas de Gran Canaria
Research Site, Göttingen
Research Site, Verona
Research Site, Memphis
Research Site, Santander
Research Site, Düsseldorf
Research Site, Taichung
Research Site, Seville
Research Site, Seville
Research Site, Reggio Emilia
Research Site, Nantes
Research Site, Cleveland
Research Site, Essen
Research Site, Valencia
Research Site, Bilbao (Vizcaya)
Research Site, Barakaldo
Research Site, Zaragoza
Research Site, Florence
Research Site, Siena
Research Site, Pisa
Research Site, Lille
Research Site, Iesi
Research Site, Torrette AN
Research Site, Chicago
Research Site, Fairway
Research Site, Strasbourg
Research Site, Lyon
Research Site, Bari
Research Site, Paris
Research Site, Paris
Research Site, North Richland Hills
Research Site, Freiburg im Breisgau
Research Site, Kaohsiung City
Research Site, Phoenix
Research Site, Las Vegas
Research Site, Santa Monica
Research Site, Erlangen
Research Site, Irvine
Research Site, Catania
Research Site, Seattle
Research Site, Messina
Research Site, Murdoch
Research Site, Belém
Research Site, Belo Horizonte
Research Site, Juiz de Fora
Research Site, Natal
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Salvador
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, Serra
Research Site, Vitória
Research Site, Halle
Research Site, Jena
Research Site, Roma
Research Site, Roma
Research Site, Rome
Research Site, Bunkyō City
Research Site, Hiroshima
Research Site, Iruma-Gun
Research Site, Nagoya
Research Site, Narita-shi
Research Site, Okayama
Research Site, Osaka
Research Site, Sapporo
Research Site, Sendai
Research Site, Urayasu-shi
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Altındağ-Ankara
Research Site, Edinburgh
Research Site, Liverpool
Research Site, London
Research Site, Salford
Research Site, West Bromwich
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY